Jim Simons Renaissance Technologies
AUM
$64.5B
1-Year Est. Return
42.73%
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
This Fund
S&P 500
1 Year Est. Return
+42.73%
AUM
$75.8B
AUM Growth
+$582M
(+0.77%)
Holding
4,038
Top Buys
| 1 | +$546M | |
| 2 | +$480M | |
| 3 | +$362M | |
| 4 |
Meta Platforms (Facebook)
META
|
+$350M |
| 5 |
Coca-Cola
KO
|
+$266M |
Top Sells
| 1 | +$1.04B | |
| 2 | +$800M | |
| 3 | +$516M | |
| 4 |
Netflix
NFLX
|
+$326M |
| 5 |
NVIDIA
NVDA
|
+$313M |
Sector Composition
| 1 | Technology | 21.72% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 11.8% |
| 4 | Communication Services | 10.53% |
| 5 | Financials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Vanda Pharmaceuticals
VNDA
$521M
| $17.3M | 0.02% |
3,476,925
+29,465
|
|
||
802
Leonardo DRS
DRS
$12B
| $17.3M | 0.02% |
381,994
+124,794
|
|
||
|
MRX
803
Marex Group
MRX
$2.51B
| $17.3M | 0.02% |
514,887
+93,800
|
|
||
804
C3.ai
AI
$1.25B
| $17M | 0.02% |
980,600
+172,600
|
|
||
805
First American
FAF
$6.69B
| $17M | 0.02% |
264,500
+66,555
|
|
||
806
Nathan's Famous
NATH
$411M
| $17M | 0.02% |
153,356
-12,089
|
|
||
807
Teradata
TDC
$2.45B
| $17M | 0.02% |
788,595
-376,762
|
|
||
808
Tetra Tech
TTEK
$8.39B
| $16.9M | 0.02% |
507,700
+115,200
|
|
||
809
Graham Corp
GHM
$886M
| $16.9M | 0.02% |
308,668
-16,400
|
|
||
810
Idacorp
IDA
$7.82B
| $16.9M | 0.02% |
128,200
+24,700
|
|
||
811
AbCellera Biologics
ABCL
$1.06B
| $16.9M | 0.02% |
3,360,729
+53,300
|
|
||
812
Acuity Brands
AYI
$8B
| $16.9M | 0.02% |
49,000
-15,600
|
|
||
813
Weis Markets
WMK
$1.63B
| $16.9M | 0.02% |
234,736
-21,400
|
|
||
814
Arhaus
ARHS
$1B
| $16.8M | 0.02% |
1,584,800
+1,095,300
|
|
||
815
Strategic Education
STRA
$1.84B
| $16.8M | 0.02% |
195,518
-18,800
|
|
||
816
CareDx
CDNA
$871M
| $16.8M | 0.02% |
1,155,598
-100
|
|
||
817
Healthcare Realty
HR
$6.27B
| $16.8M | 0.02% |
+929,372
|
|
||
818
Macy's
M
$4.53B
| $16.7M | 0.02% |
934,064
+294,500
|
|
||
819
BridgeBio Pharma
BBIO
$13.5B
| $16.7M | 0.02% |
322,246
+76,300
|
|
||
820
Visteon
VC
$2.39B
| $16.7M | 0.02% |
139,600
-24,700
|
|
||
821
Applied Industrial Technologies
AIT
$9.54B
| $16.7M | 0.02% |
+63,950
|
|
||
822
ASE Group
ASX
$47B
| $16.7M | 0.02% |
+1,504,285
|
|
||
823
Gartner
IT
$11.7B
| $16.5M | 0.02% |
62,909
-151,100
|
|
||
824
Zeta Global
ZETA
$4.36B
| $16.5M | 0.02% |
829,298
-1,461,112
|
|
||
825
Eversource Energy
ES
$27.4B
| $16.5M | 0.02% |
231,580
-206,400
|
|